Efficacy of Brincidofovir in Pediatric Stem Cell Transplant Recipients With Adenovirus Infections.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the Pediatric Infectious Diseases Society"
DOI: 10.1093/jpids/piab072
Abstract: BACKGROUND Adenovirus (AdV) infections are of particular concern in pediatric hematopoietic stem cell transplantation (HSCT) recipients as therapeutic options are limited. Brincidofovir (BCV) is the lipid-conjugated pro-drug of cidofovir (CDV) with oral bioavailability and higher… read more here.
Keywords: stem cell; hsct recipients; adv dnaemia;